Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats
Author(s) -
Roberto Miatello,
Mary Carmen Vázquez,
Nicolás Federico Renna,
Montserrat Cruzado,
Amira Ponce Zumino,
Norma Risler
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.12.012
Subject(s) - tbars , medicine , endocrinology , enos , endothelial dysfunction , lipid peroxidation , insulin resistance , resveratrol , thiobarbituric acid , blood pressure , fructose , nitric oxide , oxidative stress , nitric oxide synthase , insulin , pharmacology , biochemistry , biology
There seems to be a link between the cluster of risk factors known as insulin resistance syndrome with endothelial dysfunction. Resveratrol (3,4,5-trihydroxyestilbene) (RV), an antioxidant found in many components of the human diet, has been proposed as an effective agent in the prevention of several pathologic processes. This study examined the effect of chronic administration of RV on endothelial nitric oxide synthase (eNOS) activity in cardiovascular tissues and on plasma lipid peroxidation in fructose-fed rats (FFR), an experimental model of this syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom